美國100家不同業種企業的生物技術發展及事業化動向 是由出版商Fuji-Keizai U.S.A., Inc.在2007年02月所出版的。
這份英文市場調查報告書包含200 PAGES 價格從美金995起跳。
生物科技的發展及事業化如今已超越生物科技企業或製藥企業的範疇，滲透到一般的不同業種的企業當中，可預測將出現非常活躍的投資活動。但該活動不像生物科技專門企業那樣把所有資訊都已搬到檯面上來，相反地，可以說都在檯面下悄悄地進行。
專門於資訊科技、生物科技、奈米科技3大領域市場調查、顧問服務的美國市調公司Fuji-Keizai U.S.A., Inc. (總公司：New York City)，針對美國不同業種企業的生物科技發展及事業化動向進行調查分析及預測，並出版報告書 "Comprehensive Analysis of R&D and Commercialization for Related Biotechnologies from Non-Biotechnology/Non-Pharmaceutical Companies 100"。
本報告書內容包括：不同業種企業進行生物科技研究及發展的方式、該技術進入的領域、目標產品、產品商業化、進入領域的市場 規模、進行策略聯盟／購併的事業部門或集團等。資訊搜集採訪談及文獻搜尋方式。內容綱要摘記如下：
※本報告書可購買日文版。購買時，請選擇本頁下方價格訊息處的"Japanese Version" 。
調查目標企業
- 一般食品／飲料及食品／飼料企業：17家
- 化學企業：12家
- IT企業（電腦・硬體／軟體、半導體）：10家
- 非製藥醫療企業：10家
- 大學研究中心：12家
- 其他產業（航空・太空、汽車、電子、能源、紙／紙漿、個人護理產品）：39家
調查目的
調查結果摘要
第1章 R＆D趨勢及方向
第2章 不同業種企業的R&D趨勢
- 19個產業的詳細介紹
- 不同業種企業的生物科技研究・發展領域
- 不同業種企業的生物科技研究・發展領域
- 一般食品／飲料及食品／飼料企業
- 化學企業
- IT企業（電腦・硬體／軟體、半導體）
- 非製藥醫療企業
- 大學研究中心
- 其他產業（航空・太空、汽車、電子、能源、紙／紙漿、個人護理產品）
- 個別企業活動相關注意事項
- 不同業種企業進入的市場區隔的規模及其中的企業
圖表
Abstract
Research Objectives
This Fuji-Keizai USA report explores research and development activities,
business operations, investments and overall policies on biotechnology from
the non-pharmaceutical, non-biotech company perspective. The organizations
included in this report were selected because their core business is outside
pure-play biotechnology and pharmaceutical drug development. The purpose is to
understand to what extent, and why, industries such as IT, chemical companies,
electronics giants, energy companies, among others, have an interest in
biotechnology.
Target Companies
We start with a big picture of 100 non-pharma, non-biotech organizations. The
organizations are predominantly U.S. Fortune 500 and European Fortune Global
500 businesses, as well as top U.S. hospitals and educational institutions.
Next, we look at a piece of that organization - the divisional picture - and
describe the business unit or other internal group, often within R&D, that is
advancing biotechnology, either through commercialization of a product,
internal research and/or a strategy of partnerships or acquisition. Our
sources were publicly available data and phone interviews. Because the
organizations come from different industrial sectors, their uses for
biotechnology range from medicine, to consumer products such as clothing and
food, to biofuel production. One of more biotechnology-related projects at
each of the companies is described.
Biotechnology Defined
Biotechnology is synonymous with genomics (the study of genes) and proteomics
(the study of proteins), where molecular biology and information technology
are the tools used by scientists to develop advanced drugs. Because our scope
is beyond pharmaceutical biotech alone, we have broadened the definition of
biotechnology for this report to mean any technology where biological
substances (e.g., human cells, tissue, plants, microorganisms, enzymes, etc.)
are converted into a marketable product, system or process for medical or/and
industrial application.
Overview of R&D Trends
- 1. Development of drugs or therapies to improve human health is still a
primary focus of biotechnology research being done outside of the
pharmaceuticals industry.
- 2. Commercialization of biotechnologies as applied to industrial processes
is the next wave.
- 3. Fortune 500 companies have or are refashioning their role in the
biotech universe in the face of marketplace realities.
- 4. Major consumer-oriented companies are showing a willingness to get
involved in a new generation of biotech food research.
Table of Contents
- 1. Overview if R&D Trends and Directions
- 2. R&D Trends by Companies
- 2.1 Percent (%) Share by Company Type (Breakdown)
- 2.2 Percent (%) Share by Target R&D Segment
- 2.3 Share by Target R&D Segment, by Company Type
- 2.4 Other Analysis Based on Individual Company' s Activity
- 2.5 Market Size and R&D
- 3. Case Studies of 100 Companies
- Common Research Item
- 1) Company Name and Contact Information
- 2) Biotechnology Division Name and Contact Information
- 3) Division' s Function within Organization (Why does the company need
this kind of Division? Why does it invest in this area of biotech
development?)
- 4) Division Information (# of staff, budget, etc)
- 5) R&D description (technology, application, etc)
- 6) Technology or/and Application Competitive Advantages
- 7) Strategic Alliances
- 8) Business Segment: Market size Forecast
